TrialArthritis research & therapy2012

Double-blind, placebo-controlled randomized trial with adalimumab for treatment of juvenile onset ankylosing spondylitis (JoAS): significant short term improvement.

Gerd Horneff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.